Literature DB >> 16382447

Shwachman syndrome as mutator phenotype responsible for myeloid dysplasia/neoplasia through karyotype instability and chromosomes 7 and 20 anomalies.

Emanuela Maserati1, Antonella Minelli, Barbara Pressato, Roberto Valli, Barbara Crescenzi, Maurizio Stefanelli, Giuseppe Menna, Laura Sainati, Furio Poli, Claudio Panarello, Marco Zecca, Francesco Lo Curto, Cristina Mecucci, Cesare Danesino, Francesco Pasquali.   

Abstract

An investigation of 14 patients with Shwachman syndrome (SS), using standard and molecular cytogenetic methods and molecular genetic techniques, showed that (1) the i(7)(q10) is not, or not always, an isochromosome but may arise from a more complex mechanism, retaining part of the short arm; (2) the i(7)(q10) has no preferential parental origin; (3) clonal chromosome changes, such as chromosome 7 anomalies and del(20)(q11), may be present in the bone marrow (BM) for a long time without progressing to myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML); (4) the del(20)(q11) involves the minimal region of deletion typical of MDS/AML; (5) the rate of chromosome breaks is not significantly higher than in controls, from which it is concluded that SS should not be considered a breakage syndrome; (6) a specific kind of karyotype instability is present in SS, with chromosome changes possibly found in single cells or small clones, often affecting chromosomes 7 and 20, in the BM. Hence, we have confirmed our previous hypothesis that the SS mutation itself implies a mutator effect that is responsible for MDS/AML through these specific chromosome anomalies. This conclusion supports the practice of including cytogenetic monitoring in the follow-up of SS patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16382447     DOI: 10.1002/gcc.20301

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  20 in total

1.  Mislocalization or low expression of mutated Shwachman-Bodian-Diamond syndrome protein.

Authors:  Masafumi Yamaguchi; Kingo Fujimura; Hirokazu Kanegane; Hanae Toga-Yamaguchi; Rajesh Chopra; Naoki Okamura
Journal:  Int J Hematol       Date:  2011-06-10       Impact factor: 2.490

Review 2.  Genetic predisposition to MDS: clinical features and clonal evolution.

Authors:  Alyssa L Kennedy; Akiko Shimamura
Journal:  Blood       Date:  2019-01-22       Impact factor: 22.113

3.  The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid transformation in inherited bone marrow failure syndromes.

Authors:  Michaela Cada; Catherin I Segbefia; Robert Klaassen; Conrad V Fernandez; Rochelle A Yanofsky; John Wu; Yves Pastore; Mariana Silva; Jeffrey H Lipton; Josee Brossard; Bruno Michon; Sharon Abish; MacGregor Steele; Roona Sinha; Mark Belletrutti; Vicky Breakey; Lawrence Jardine; Lisa Goodyear; Lillian Sung; Mary Shago; Joseph Beyene; Preeti Sharma; Bozana Zlateska; Yigal Dror
Journal:  Haematologica       Date:  2015-02-14       Impact factor: 9.941

Review 4.  Shwachman-Diamond syndrome.

Authors:  C Dall'oca; M Bondi; M Merlini; M Cipolli; F Lavini; P Bartolozzi
Journal:  Musculoskelet Surg       Date:  2011-12-27

Review 5.  Shwachman-Diamond Syndrome: Molecular Mechanisms and Current Perspectives.

Authors:  Valentino Bezzerri; Marco Cipolli
Journal:  Mol Diagn Ther       Date:  2019-04       Impact factor: 4.074

6.  Comparative genomic hybridization on microarray (a-CGH) in constitutional and acquired mosaicism may detect as low as 8% abnormal cells.

Authors:  Roberto Valli; Cristina Marletta; Barbara Pressato; Giuseppe Montalbano; Francesco Lo Curto; Francesco Pasquali; Emanuela Maserati
Journal:  Mol Cytogenet       Date:  2011-05-09       Impact factor: 2.009

7.  Shwachman-Bodian Diamond syndrome is a multi-functional protein implicated in cellular stress responses.

Authors:  Heather L Ball; Bing Zhang; J Jacob Riches; Rikesh Gandhi; Jing Li; Johanna M Rommens; Jeremy S Myers
Journal:  Hum Mol Genet       Date:  2009-07-14       Impact factor: 6.150

Review 8.  Shwachman-Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment.

Authors:  Lauri Burroughs; Ann Woolfrey; Akiko Shimamura
Journal:  Hematol Oncol Clin North Am       Date:  2009-04       Impact factor: 3.722

9.  Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L.

Authors:  Dong-Hui Chen; Jennifer E Below; Akiko Shimamura; Sioban B Keel; Mark Matsushita; John Wolff; Youngmee Sul; Emily Bonkowski; Maria Castella; Toshiyasu Taniguchi; Deborah Nickerson; Thalia Papayannopoulou; Thomas D Bird; Wendy H Raskind
Journal:  Am J Hum Genet       Date:  2016-06-02       Impact factor: 11.025

Review 10.  Genetic Predisposition to Myelodysplastic Syndrome in Clinical Practice.

Authors:  Kristen E Schratz; Amy E DeZern
Journal:  Hematol Oncol Clin North Am       Date:  2020-01-06       Impact factor: 3.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.